non-opioid pain treatments

Latigo raises $150m for non-opioid painkiller push
Pharmaphorum
Mon, 03/17/25 - 10:06 am
Latigo
funding
non-opioid pain treatments
Vertex Pharmaceuticals
Journavx
Tris to ask for approval of dual-acting pain drug
BioPharma Dive
Thu, 03/6/25 - 11:26 am
Tris Pharma
acute pain
cebranopadol
non-opioid pain treatments
FDA
Lexicon’s non-opioid therapy for DPNP beats placebo in pain reduction
Clinical Trials Arena
Mon, 03/3/25 - 11:56 pm
Lexicon Pharmaceuticals
non-opioid pain treatments
clinical trials
diabetic peripheral neuropathic pain
LX-9211
Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx
Fierce Pharma
Tue, 02/11/25 - 09:54 pm
Vertex
non-opioid pain treatments
Journavx
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
BioPharma Dive
Thu, 01/30/25 - 11:36 pm
Vertex Pharmaceuticals
non-opioid pain treatments
FDA
Journavx
A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
Pharma Voice
Wed, 01/29/25 - 11:15 am
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
Tris Pharma's alternative to opioids reduces post-surgery pain in phase 3 trial ahead of NDA submission
Fierce Biotech
Wed, 01/22/25 - 11:58 am
Tris Pharma
clinical trials
post-surgical pain
non-opioid pain treatments
cebranopadol
5 FDA decisions to watch in the first quarter of 2025
BioPharma Dive
Mon, 01/6/25 - 06:54 pm
FDA
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
GSK
vaccines
MenABCWY
meningitis
Alnylam
vutrisiran
transthyretin amyloid cardiomyopathy
Soleno
diazoxide choline
Prader Willi syndrome
Sanofi
hemophilia
fitusiran
Vertex's pain trial hits endpoint but sinks stock as placebo comparison spooks investors
Fierce Biotech
Thu, 12/19/24 - 10:22 am
Vertex Pharmaceuticals
suzetrigine
painkillers
non-opioid pain treatments
ICER finds Vertex's non-opioid pain drug 'slightly' cost-saving, with fewer addiction risks
First Word Pharma
Mon, 12/9/24 - 08:58 pm
Vertex Pharmaceuticals
VX-548
ICER
non-opioid pain treatments
In pain R&D, Vertex withstood tough times to bring non-opioid suzetrigine to cusp of FDA approval
Fierce Biotech
Mon, 10/28/24 - 10:20 am
Vertex Pharmaceuticals
R&D
non-opioid pain treatments
suzetrigine
Levicept says non-opioid drug cuts arthritis pain in phase 2
Pharmaphorum
Wed, 08/7/24 - 11:18 am
Levicept
non-opioid pain treatments
osteoarthritis pain
clinical trials
LEVI-04
Vertex gets January 30 decision date for non-opioid pain med suzetrigine
Businesswire
Tue, 07/30/24 - 06:40 pm
Vertex Pharmaceuticals
suzetrigine
non-opioid pain treatments
FDA
Vertex inches closer to acute pain market with FDA application acceptance
Fierce Biotech
Thu, 04/18/24 - 11:10 am
Vertex Pharmaceuticals
VX-548
acute pain
painkillers
FDA
non-opioid pain treatments
Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A
BioSpace
Wed, 02/14/24 - 11:34 am
Latigo
non-opioid pain treatments
funding
Non-opioid drug from Vertex cuts pain in major trial tests
BioPharma Dive
Tue, 01/30/24 - 10:18 am
Vertex Pharmaceuticals
non-opioid pain treatments
clinical trials
Eli Lilly licenses non opioid pain med for $40M upfront
Seeking Alpha
Thu, 03/2/23 - 09:58 am
Eli Lilly
Confo Therapeutics
non-opioid pain treatments
CFTX-1554
A Glimmer of Hope in the Quest for a Nonaddictive Painkiller
Bloomberg
Thu, 11/3/22 - 11:08 am
Vertex Pharmaceuticals
VX-548
non-opioid pain treatments
Acadia's prized pain drug from $52M buyout flops its first test
Endpoints
Tue, 04/19/22 - 10:57 am
Acadia Pharmaceuticals
CerSci Therapeutics
M&A
ACP-044
non-opioid pain treatments
Vertex claims success on its non-opioid pain drug, pushing candidate into pivotal trials
Endpoints
Thu, 03/31/22 - 10:40 am
Vertex Pharmaceuticals
non-opioid pain treatments
clinical trials
VX-548

Pages